Ob-X Watermix Classic
Product Overview
Targeted Visceral Fat Reduction — Clinically Proven, MFDS-Approved Formula
This advanced formula is designed to help reduce dangerous visceral fat—a key contributor to obesity-related health risks. Backed by clinical studies and approved by the Korean Ministry of Food and Drug Safety (MFDS), this product offers a safe and effective solution for targeted belly fat reduction.
Key Features & Benefits
Clinically Proven Efficacy
• Over 20% reduction in visceral fat demonstrated in hospital-based clinical trials
• Powered by Ob-X, a patented herbal extract registered with the MFDS
Safe for Long-Term Use
• No caffeine detected
• Non-habit forming and free from common side effects
• MFDS-approved for both safety and functionality
Science-Based Mechanism
• Targets the angiogenesis (blood vessel formation) process that fuels visceral fat growth
• More effective than exercise alone: studies show that even 32 km of weekly jogging over 8 months results in only ~6.9% visceral fat reduction
Simple Daily Intake
• Take just 1 stick per day—anytime, anywhere
• No need for complicated routines or restrictive diets
Why Choose This Product?
Visceral fat is more metabolically active and harmful than subcutaneous fat. Unlike typical weight-loss supplements, this formula directly inhibits the nutrient supply to visceral fat, offering a truly targeted approach. Whether you're looking to enhance your health, support a diet program, or expand your functional food portfolio, this product offers a trusted, premium-grade solution.
Certifications & Regulatory Info
• Registered and approved by MFDS (Ministry of Food and Drug Safety, Korea)
• Produced under GMP-compliant facilities
• Ingredient: Ob-X – Natural extracts derived from three traditionally consumed plants: mulberry leaf (Morus alba), lemon balm (Melissa officinalis), and Artemisia capillaris (Yin Chen wormwood).
Packaging & Delivery
Form |
Powder Stick (Stick Pack) |
Dosage |
1 stick daily |
Packaging |
Individual stick packs / [e.g., 15 sticks per box] |
Company Overview
AngioLab is a bio-venture company which has developed a medicine with angiogenesis inhibitors for treating angiogenesis-related diseases.
Since its inception in 1999, AngioLab has been steadfast in its commitment to the development of angiogenesis inhibitors aimed at treating a range of diseases related to angiogenesis.
Leveraging our expertise in oral angiogenesis inhibitors, AngioLab has successfully carried out Phase II clinical trials for several conditions, including neovascular age-related macular degeneration, abdominal obesity, metabolic dysfunction-related steatohepatitis, otitis media with effusion, and periodontitis. These trials were conducted to ascertain both the safety and efficacy of our products.
Furthermore, we have pioneered the development of Ob-X, a health functional food that inhibits angiogenesis. This innovative product has been acknowledged as a functional ingredient with health claim by the MFDS. It is currently available in Korea and has been exported to numerous countries worldwide.
AngioLab is committed to enhancing the quality of life by developing treatments for intractable diseases. Our ultimate goal is to assist individuals in leading long, healthy lives, free from diseases.
We deeply appreciate your ongoing support and look forward to continuing our journey towards making significant contributions to healthcare and medicine.